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Phosphate depletion impairs insulin secretion by pancreatic
islets
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Phosphate depletion impairs insulin secretion by pancreatic islets.
Phosphate depletion (PD) is associated with resistance to the peripheral
action of insulin and with glucose intolerance. However, data on the
effect of PD on insulin secretion are not consistent, and were derived
indirectly by measurements of blood levels of insulin during intrave-
nous glucose tolerance test (IVGTT) or with hyperglycemic clamp
technique. Direct evidence for an effect of PD on insulin secretion by
pancreatic islets is not available, and the potential mechanisms through
which PD may affect insulin secretion are not known. We performed
IVGTT, examined in vitro insulin secretion by pancreatic islets, and
evaluated various factors involved in insulin secretion in PD and pair
weighed (PW) rats. PD animals had fasting hyperglycemia and normal
plasma insulin levels, and displayed abnormal IVGTT as compared to
PW rats. Both initial and late phases of D-glucose-induced insulin
secretion from islets were markedly and significantly (P < 0.01) lower
than from islets of PW rats. In contrast, D-glyceraldehyde-induced
insulin release in PD rats was similar to that of PW rats. [H3]2-
deoxyglucose uptake by islets and their cyclic AMP content after
exposure to D-glucose, D-glyceraldehyde or forskolin were not dif-
ferent among the two groups of animals. Insulin content in PD islets was
modestly but significantly (P < 0.01) higher than PW islets. In PD islets,
ATP content and the ATP/ADP ratio at basal state and after incubation
with 16.7 m D-glucose were significantly (P < 0.01) lower and resting
cytosolic calcium was significantly (P < 0.01) higher than in PW islets.
Lactic acid output by islets from PD rats was significantly (P < 0.01)
less than that from islets of PW rats. The data show that: 1) PD rats
have glucose intolerance and marked reduction in insulin secretion; 2)
resting cytosolic calcium of pancreatic islets of PD rats is elevated; 3)
the defect in insulin secretion is not due to abnormal glucose uptake or
cAMP production by or insulin content of the islets but due to a reduced
ATP content, elevated resting cytosolic calcium and/or defective glu-
cose metabolism by the islets. This latter defect is most likely due to
reduced ATP content which is required for phosphorylation of glucose
to fructose bisphosphate. 4) The decrease in ATP content of islets is
most likely due to both PD per se and the associated high resting
cytosolic calcium, since chronic rise in the latter is known to inhibit
ATP production.
Several observations indicate that phosphate depletion (PD)
may affect glucose metabolism. First, Gold, Massry and Frie-
dler [1] reported that fasting blood glucose levels were elevated
in dogs with PD. They suggested that PD is associated with
glucose intolerance which could be due to peripheral resistance
to insulin, to reduced insulin secretion by pancreatic islets or to
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both, Second, Harter et al [2] found marked impairment in
intravenous glucose tolerance test in dogs with chronic PD,
despite significant rise in blood insulin levels during the test.
They concluded that PD is associated with reduced responsive-
ness to insulin but that the secretion of the hormone is not
affected. Third, Simonson and DeFronzo [3], utilizing euglyce-
mic and hyperglycemic clamp techniques, demonstrated the
presence of resistance to insulin action in six hypophosphate-
mic humans. Blood insulin levels in the hypophosphatemic
subjects during the hyperglycemic clamp studies were not
different from those of control subjects. They suggested that
insulin secretion might have been impaired in hypophosphate-
mic subjects since the resistance to the action of insulin in these
subjects should have triggered greater insulin secretion.
Direct evidence for an effect of PD on insulin secretion by
pancreatic islets is not available. Also, if PD is associated with
reduced insulin secretion, the mechanisms responsible for such
an effect are not known. The evaluation of these issues are
essential for the understanding of the biology of PD-induced
glucose intolerance.
The present study examined glucose-induced insulin secre-
tion by pancreatic islets isolated from PD rats and pair-weighed
animals and evaluated the mechanisms that could contribute to
reduced insulin secretion in PD.
Methods
Male Sprague-Dawley rats weighing 125 to 150 g were used.
The animals were divided into two groups. The first was fed a
low phosphate diet (phosphorus content of 0.03%, ICN Bio-
chemicals, Cleveland, Ohio, USA) and the second received the
control diet (phosphorus content 0.99%, Wayne Research An-
imal Diets, Bartonville, Illinois, USA) in a quantity adjusted to
maintain their weight equal to the PD animals; this second
group is referred to as pair-weighed (PW). The other compo-
nents of the two diets were comparable except for calcium
(protein 20 vs. 24%; fat 4.5 vs. 4.5% and calcium 0.60 vs.
1.48%). The low phosphate diet should contain lower calcium
content, otherwise marked hypercalcemia may develop and
endanger the life of the animal. The rats had free access to
deionized water all the time.
Blood samples for the measurement of calcium, phosphorus,
magnesium, glucose and insulin were obtained weekly after
fasting for 12 hours. The blood was withdrawn from the tail vein
under light anesthesia. Plasma creatinine was measured on the
day of sacrifice of the animals. All studies detailed below were
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performed in both PD and PW rats after six weeks of ingesting
the respective diet.
Intravenous glucose tolerance test (IVGTT)
One hour IVGTT was done in PD and PW rats. The day
before the study, all rats were weighed and anesthetized with
intraperitoneal injection of 40 to 50 mg sodium phenobarbital/kg
body weight (Western Medical Supply, Arcadia, California,
USA). Through an incision of the ventral surface of the neck,
the jugular vein and carotid artery were cannulated with PE-lO
tubing filled with a solution of sodium heparin (1000 IU/ml in
0.9% saline). The tubings were led subcutaneously to emerge at
the base of the neck. After surgery, the animals were housed in
individual cages and given the assigned diet and water. IVGTT
was performed the following day after 12 hours of fasting and
while the rats were awake. The animals received 0.5 g of
D-glucose/kg body weight as an intravenous bolus injection. A
total of six blood samples of 100 pi each were collected serially
before and at 5, 15, 30, 45, and 60 minutes after the glucose
injection from the arterial line for measurement of glucose and
insulin.
Pancreatic islet preparation
The animals were sacrificed by decapitation and the pancreas
was removed, dissected free of adipose tissue and lymph nodes.
Islets of Langerhans were isolated by the collagenase digestion
method of Lacy and Kostianovsky [41 and picked free of
exocrine tissue under a dissecting microscope.
Studies of insulin secretion by islets
The insulin secretion from islets of PD and PW animals were
evaluated under static and dynamic conditions. The static and
dynamic studies were done according to methods previously
reported [5—7]. In the dynamic studies, the first six collections
(6 mm) represented the basal level of insulin release during
perifusion with 2.8 mivi D-glucose. Thereafter, the D-glucose
concentration in the perifusate was increased to 16.7 m and an
additional 35 samples were collected, and insulin concentra-
tions were determined in the various samples of the effluent. In
another group of studies the insulin secretagogue was 10 mM
D-glyceraldehyde. In all the studies, the changes from baseline
with time were examined by calculating the area under the
curve for each study. The calculations of the areas under the
curve allowed us to estimate insulin release during the initial
phase (8 mm) between minutes 2 to 10 and the total insulin
release (33 mm between mm 2 and 35).
[H3]2-deoxy glucose uptake by islets
[H3]2-deoxyglucose (Amersham Co., Arlington Heights, Illi-
nois, USA specific activity 17 Ci/mmol glucose) uptake was
measured using 400 islets according to a method described by
Draznin et al [81. The islets were disrupted into single cells as
described below under the methodology for the measurement of
cytosolic calcium. A total of 0.2 /LCi of [H3]2-deoxyglucose
were added to 1 ml of islet suspension while on ice. Samples of
100 d were taken at 0 time, transferred to a microcentrifuge
tube containing 100 d of silicone oil, and centrifuged in a
Beckman 152 microfuge (Beckman Instrument Corporation,
Palo Alto, California, USA). The pellet was counted for radio-
activity in a Beckman liquid scintillation counter. These counts
Table 1. Effect of various concentrations of trichloroacetic acid
(TCA) on the extraction of ATP from pancreatic islets of normal rats
ATP pmollislet
TCA concentration 2.8 16.7
% (mM) D-glucose
0.5 7.8 0.20 7.8 0.32
1.0 12.1 0.91 15.6 0.59
2.0 14.5 0.15 23.3 1.31
3.5 12.8 0.95 20.5 1.22
5.0 12.3 0.84 21.1 1.83
8.0 14.0 1.10 20.5 1.95
Data are mean SE of 4 studies.
were considered to represent the non-specific binding of [H3]2-
deoxyglucose to the islets. The remaining islet suspension was
incubated in a shaker bath at 37°C for five minutes and
thereafter 100 d sample was transferred to a microcentrifuge,
tube containing 100 d of silicone oil and centrifuged. The pellet
was counted as described above. The difference between the
counts at five minutes and at time 0 was considered to represent
glucose uptake by the islets.
Insulin content of islets
Insulin content of islets was measured in groups of 15 islets
according to the method of Davoren [91. The islets were first
sonicated. Trichloroacetic acid (10%) was then added and the
mixture centrifuged at 1500 g for 10 minutes. The supernate was
collected and the pellet was washed twice with trichloroacetic
acid (5%) and centrifuged. Insulin was extracted from the
supernate by acid ethanol (1.5 N HC1 in 70% ethanol) overnight.
Adenine nucleotides content of islets
Both ATP and ADP content of islets were measured simul-
taneously by the methods of Ashcroft, Weerasinghe and Randle
[101 and of Lundin et al [11]. The islets were placed in 400 .d
Krebs-Ringer-bicarbonate (KRBHA) incubation medium con-
taining 2.8, 16.7 mM D-glucose and incubated for 30 minutes. At
the end of the incubation, 200 pA of the medium containing the
islets were mixed with trichloroacetic acid (TCA) with a final
concentration of 2.5%. The tube containing the mixture was
immersed in liquid nitrogen and stored at —70°C. On the day of
the assay, the mixture was thawed and neutralized with 2 N
KHCO3. Samples of 50 pA of the mixture were assayed for ATP
before and after conversion of ADP to ATP by phosphoenol
pyruvate (0.2 M) and pyruvate kinase (10 mg/mI). The difference
between the two values represents the ADP content. The ATP
measurements were made by the firefly luminescence assay
with the LAD 535 Luminometer (Turner Design, Sunnyvale,
California, USA). ATP standards were prepared with KRBHA
medium and contained the same amount of TCA and bicarbon-
ate as the islet extracts. The choice of this concentration of
TCA was based on our finding that the extraction of ATP from
pancreatic islets is not enhanced by the use of higher concen-
tration of TCA (Table 1).
Lactate assay
Lactic acid output by islets was determined after their
incubation with 2.8 and 16.7 mrt D-glucose utilizing the method
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of Sener and Malaisse [121. The assay estimates the level of
NADH liberated at the end of the reaction generated by the
addition of 0.5 m NAD, 50 g lactic dehydrogenase, 2 mM
glutamate, 50 g glutamic-pyruvic transaminase, and 50 mM
2-amino-2-methyl-propanol to a cuvette with a final volume of 2
ml containing either islets or a standard. The measurement of
NADH was done with Perkin Elmer fluorometer at excitation
wavelength of 340 nm and emission wavelength of 450 nm. The
difference between lactic acid output by islets incubated with
2.8 and 16.7 m D-glucose was calculated and this net lactic
acid output was considered to be produced by oxidation of
glucose by the islets.
Cyclic AMP of islets
Cyclic AMP content of islets was measured after incubation
of islets from both PD and PW rats with 16.7 mvt D-glucose,
16.7 mi D-glucose and 10 LM forskolin, or 2.8 mi D-glucose
and 10 mi D-glyceraldehyde. The studies were done on 10
islets suspended in 500 d of incubation media containing the
various secretagogues. Cyclic AMP content was measured as
follows: at the end of 20 minutes of incubation at 37°C, the islets
were lysed by the addition of 120 il 10% perchloric acid and the
solution was then neutralized with 90 tl of potassium carbonate
and centrifuged at 3,000 g for 10 minutes. The supernatant was
saved. The pellet was washed and centrifuged two more times
and the supernatant was saved after each centrifugation. The
pooled aqueous extract was dried at 60°C. Prior to cyclic AMP
assay the extract was reconstituted with 1 ml of assay buffer
and cyclic AMP was measured utilizing the cyclic AMP (1251)
assay kit (Amersham Co.).
Cytosolic calcium of islets
Cytosolic calcium of islets was measured with Fura2-AM
(Sigma Chemical Co., St. Louis, Missouri, USA) utilizing a
modification of the method described by Sussman, Leitner and
Draznin [131. The pancreatic islets were isolated utilizing the
collagenase digestion method described above and picked un-
der a dissecting microscope. Five hundred to 600 islets were
then dissociated into single cells and small clusters by shaking
in calcium and magnesium free medium supplemented with
EGTA (0.2 mglml) and trypsin (0.5 mglml) for 10 minutes at
room temperature. The suspension was then centrifuged at 500
g for three minutes and the pellet resuspended in a modified
Krebs-Ringer solution containing 135 mr'i NaCI, 5 mM KCI, 1.5
mM CaC12, 1 m MgCl2, 2 mt NaH2PO4, 6 mii HEPES, 2.8
mM D-glucose, 1 glliter bovine serum albumin (fraction V; pH
7.4). The suspension was aspirated 10 times through a 14-gauge
needle at room temperature and then incubated at 37°C for three
minutes with gentle shaking. The islets were then disrupted into
individual cells with eight aspirations through a 20-gauge nee-
dle. The cells were then centrifuged at 500 g for three minutes
and washed in the above solution. Loading of the cells with
Fura2-AM was done by incubating them with 2 M of
Fura2-AM for 30 minutes. This was followed by washing and
centrifugation at 500 g for three minutes at room temperature.
Measurement of fluorescence was done with Perkin-Elmer
fluorescence spectrophotometer Model LS SB at excitation
wavelength of 340 nm and emission wavelength of 510 nm.
Maximal fluorescence (Fmax) and minimal fluorescence (Fmin)
were estimated as previously reported [14, 15]. The cells were
lysed with digitonin (40 g/ml) to obtain Fmax. Next, 10 mM
EGTA and sufficient NaOH to elevate the pH to 8.5 were added
to obtain the minimum fluorescence. Cells were washed before
each experiment, and the above mentioned calibration for the
Fura2 signal was performed after each experiment. To eliminate
the effect of autofluorescence due to the cuvette, medium and
islets, fluorescence was measured with empty cuvette, after
addition of medium and after addition of cells without Fura2.
The unloaded pancreatic islets produced very minimal and
almost undetectable fluorescence. Correction for the autofluo-
rescence of the cuvette and medium was made by setting the
fluorometer on autozero before each measurement. Calculation
of cytosolic calcium was made utilizing Grynkiewicz equation
[15]. The dissociation constant for Ca2-Fura2 was assumed to
be 225 nM [13].
The measurements of calcium and magnesium concentration
in plasma were made by Perkin-Elmer atomic absorption spec-
trophotometer, Model 503 and those of creatinine and phospho-
rus by Technicon autoanalyzer (Technicon Instrument Inc.,
Tarrytown, New York, USA). Glucose was measured with the
glucose oxidase method utilizing Beckman Glucose Analyzer
II. Insulin was determined by charcoal-coated radioimmunoas-
say using rat insulin as standard [161.
Statistical analysis was done with the Clinfo computer sys-
tem. The data are presented as mean SE. Changes from base
line in parameters with multiple measurements with time (glu-
cose tolerance and dynamic insulin release) were evaluated by
calculating the area under the curve for each experiment
utilizing the trapezoidal rule. The significance of the differences
in the data obtained in PD and PW rats was evaluated by
unpaired t-test.
Results
The changes in the concentration of plasma calcium, phos-
phorus, magnesium, glucose and insulin and in the body weight
of PD and PW rats during the six weeks of feeding them the
respective diet are shown in Table 2. Both PD and PW rats
gained a small amount of weight during the six weeks of study
but there were no significant differences between the two
groups. This small gain in weight is not surprising since rats do
not ingest adequate amount of food low in phosphorus and,
therefore, their weight gain is not adequate. This observation is
similar to previously reported data [171. There was significant
fall in the concentration of plasma phosphorus by the end of the
first week of PD and the values continued to fall throughout the
study. The mean value of the plasma concentration of phospho-
rus on the day of sacrifice of the PD animals was 3.2 0.5 mg/dl
compared to 8.5 0.1 mg/dl (P < 0.01) before the initiation of
PD. The plasma concentration of phosphorus in PW rats also
fell with time but was always significantly higher than those in
PD rats. The plasma concentrations of calcium increased sig-
nificantly (P < 0.01) by the end of the first week of PD and
remained high throughout the study, and the values were
always higher than those of PW animals. The plasma concen-
tration of magnesium decreased significantly (P < 0.01) after
one week of PD and remained lower than in PW rats throughout
the study. At the time of sacrifice the concentrations of serum
creatinine in the PD (0.49 0.03 mg/dl) and PW (0.41 0.02
mgldl) rats were normal and not different. These observations
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Table 2. Body weight and plasma values of calcium, phosphorus, magnesium, glucose and insulin in phosphate depleted (PD) and paired
weighed (PW) rats
ht g
Plasma mg/dl
nglmlWeig Calcium Phosphorus Magnesium Glucose Insulin
PD PW PD PW PD PW PD PW PD PW PD PW
Before 147 144 10.2 10.5 8.5 8.4 2.48 2.56 109 108 0.58 0.52
±1.0 ±1.0 ±0.1 ±0.1 ±0.1 ±0.2 ±0.01 ±0.05 ±3.0 ±2.5 ±0.07 ±0.06
1st Week 151 153 12.5 10.4 5.1 7.5 1.51 2.67 132 110 0.54 0.52
±3.2 ±1.8 01a.b ±0.1 02a.b ±0.2 ÷005a,b ±0.04 41a,b ±2.5 ±0.04 ±0.02
2nd Week 159 160 12.6 10.4 4.0 5.9 1.50 2.60 132 107 0.67 0.65
4•3a ÷34a ÷01a,b ±0.1 ÷01a,b Øa ÷005a,b ±0.05 ÷41a,b ±1.9 ±0.05 ±o.o4
3rd Week 167 172 12.5 9.9 4.4 6.4 1.53 2.66 143 107 0.58 0.5447a 4a 02a.b ±o.r ÷01a,b ÷006a.b ±0.07 27a,b ±1.4 ±0.02 ±0.05
4th Week 169 179 12.2 9.8 4.0 5.8 1.61 2.20 134 109 0.61 0.56
±5.3 56a ±0.2'' ±0.2 01a,b ±o.la ÷007a,b ±o.osa ÷32a,b ±2.7 ±0.05 ±0.03
5th Week 171 184 12.7 9.9 3.1 5.2 1.75 2.45 149 106 0.65 0.53
±5.7a ±6.4a 02a,b ±0.l ÷01a,b ±0.la ÷005a,b ±0.04 ÷30a,b ±2.4 ÷005b ±0.02
6th Week 171 181 12.1 9.7 3.2 5.6 1.45 2.18 131 101 0.61 0.58
±6.9a ±7.0 03a.b ±0.l ±o.sab ±o.la ÷005a,b 19a,b ±2.3 ±0.03 ±0.03
Data are presented as mean ± SE of observation in 80 PD rats and 80 PW rats.
a P < 0.01 vs. data before PD or PWb P < 0.01 vs. PW
on the changes of the concentrations of plasma electrolytes in
PD and PW rats are similar to those reported previously [181.
The concentration of glucose in plasma rose significantly (P
< 0.01) by the end of the first week of PD and fasting
hyperglycemia persisted throughout the study. There was no
significant change in the plasma concentration of glucose in PW
rats. The plasma concentration of insulin in PD and PW rats did
not show significant changes.
Figure 1 shows the changes in plasma glucose during IVGTT
in PD and PW rats. The plasma concentrations of glucose
reached their peak within five minutes after the injection of the
glucose load and decreased thereafter. The PD rats displayed
glucose intolerance with the area under the curve for their
plasma glucose (11641 ± 522 mg/dl. 60 mm) being significantly
(P < 0.01) higher than that in the PW animals (9092 ± 491 mg/dl;
60 mm). There were significant increments in plasma insulin
levels in PW rats during IVGTT, but only small changes were
noted in PD rats (Fig. 2). The area under the curve for insulin in
PD rats (48 ± 3.7 nglml. 60 mm) was significantly (P < 0.01)
smaller than that in PW animals (75 ± 5.7 ng!ml. 60 mm).
In static studies with islets from PD rats, glucose-induced
insulin secretion (79 ± 9.7 pg/islet/mm) was significantly (P <
0.01) lower than that in PW rats (112 ± 7.4 pg/islet/mm). In
contrast, with D-glyceraldehyde as a secretagogue, insulin
300
200
a, (0
0 C.)
100
0
60
Time, minutes
Fig. 1. The changes in plasma glucose concentrations during intrave-
nous glucose tolerance test. Each data point represents mean value of
5 to 7 experiments and brackets denote 1 SE. Symbols are: (0) PW; (•)
PD.
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2.0
i.o
0.0
60
Time, minutes
Fig. 2. The changes in plasma insulin concentrations during intrave-
nous glucose tolerance test. Each data point represents mean value of
5 experiments and brackets denote 1 SE. Symbols are: (•) PD; (0) PW.
0 5 15 30 45
124 Zhou et al: Phosphate depletion and insulin secretion
secretion from islets of PD rats (114 11.1 pg/islet/mm) was not
different from that in PW rats (107 8.3 pg/islet/mm).
Glucose-induced insulin release during the dynamic studies is
shown in Figure 3. Both early and total insulin secretions from
islets of PD rats were significantly lower than those from islets
of PW rats. The area under the curve of early insulin release (2
to 10 mm) in PD rats (418 164 pg/islet. 8 mm) was significantly
(P < 0.01) lower than that in PW rats (752 55 pg/islet. 8 mm).
Similarly, the area under the curve of total insulin release (2 to
35 minutes) in PD rats (1647 279 pg/islet. 33 mm) was
significantly (P < 0.01) lower than that in PW rats (2757 339
pg/islet. 33 mm).
D-glyceraldehyde-induced insulin secretion is given in Figure
4. There were no significant differences between insulin secre-
tion from islets of PD and PW rats when D-glyceraldehyde was
used as a secretagogue.
There was no significant difference in [3H12-deoxyglucose
uptake by islets form PD rats (4.15 0.53 fmol/5 mm) and by
islets form PW animals (4.34 0.43 fmol/5 mm). Insulin content
was modestly but significantly (P < 0.01) higher in islets of PD
animals (62 2.5 ng/islet) compared to that of islets from PW
rats (52 2.0 ng/islet).
Table 3 provides the contents of ATP and ADP and the
ATP/ADP ratio in islets from PD and PW rats as well as the
values of net lactic acid output by these islets. Both the basal
and the glucose-stimulated ATP contents were significantly
lower (P <0.01) in PD rats than in PW animals. The ATP/ADP
ratios in the islets incubated with 2.8 or 16.7 mM D-glucose
were significantly (P < 0.01) lower in PD than in PW rats. Net
lactic acid output by islets from PD rats (73 41 pmol/islet/90
mm) was significantly (P < 0.01) lower than that by islets from
PW animals (327 54 pmol/isletI9O mm).
Glucose, D-glyceraldehyde and forskolin stimulated cyclic
AMP production by pancreatic islets, but there was no signifi-
cant difference in the cyclic AMP content of islets from PD or
PW rats in response to either of these secretagogues (Fig. 5).
Figure 6 depicts fluorescence tracings of Fura2 during the
measurements of cytosolic calcium in dispersed cells of pancre-
atic islets obtained from normal, PD and PW rats. The resting
levels of cytosolic calcium in dispersed cells of pancreatic islets
from PW rats (128 3.4 nM) were not different from those of
normal rats (137 5.1 nM). However, the values of islets from
PD rats (235 7.9 nM) were significantly (P < 0.01) higher than
those of both normal and PW rats (Fig. 7). The islets of normal,
PW and PD rats displayed an increase in cytosolic calcium
following the addition of 50 nM ionomycin. However, the rise in
cytosolic calcium in islets of PD rats in response to ionomycin
persisted for a long period of time (>9 mm) but began to decline
to a new level within one minute in islets from normal or PW
rats (Fig. 6).
Discussion
The results of the present study demonstrate that PD in rats
is associated with fasting hyperglycemia without significant rise
in plasma insulin levels. Fasting hyperglycemia has been re-
ported in PD dogs as well [1]. In addition, our data show an
abnormal response to IVGTT in PD rats demonstrating the
presence of glucose intolerance in these animals. These abnor-
malities were not present in PW rats and therefore could not be
attributed to low food intake or slow rate of growth. The
presence of glucose intolerance in PD rats is in agreement with
other reports in PD dogs [2] and in hypophosphatemic humans
[3]. Thus, it appears that the rat is an appropriate animal for the
study of the mechanisms underlying the defect in glucose
intolerance in PD.
The studies of Harter et al [21 in dogs and of Simonson and
DeFronzo [31 in hypophosphatemic humans have clearly dem-
onstrated that PD is associated with peripheral resistance to the
E
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Fig. 3. Dynamic insulin release from perifused pancreatic islets with
16.7 msi D-glucose. Each data point represents the mean value of
studies performed in 4 rats and the brackets denote 1 SE. Each study
was done in duplicate. Symbols are: (•) PD; (0) PW.
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Fig. 4. Dynamic insulin release from perifused pancreatic islets with
10 mM D-glyceraldehyde. Each data point represents the mean value of
studies done in 5 to6 rats and the brackets denote I SE. Each study was
done in duplicate. Symbols are: (•) PD; (0) PW.
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Table 3. ATP and ADP content, ATP/ADP ratio and lactic acid output of islets from PD and PW rats
ATP pmol/islet ADP pmol/islet
2.8 16.7
mat D-glucose
ATP/ADP ratio
Net lactic acid output
pmol/islet/90 mm
2.8 16.72.8 16.7
mM D-glucosemM D-glucose
PD mean
SE
N=10
PW mean
SE
N=8
6.46 lO.47a
0.33 0.79
13.77" 2479a.b
1.36 1.54
2.95 3.20
0.46 0.49
379 374
0.49 0.59
2.81 4.08a
0.47 0.69
802a,b
0.53 1.31
73 41
N=8
327 54"
N=8
a P < 0.01 vs. 2.8 mat D-glucose
b P < 0.01 vs. PD
16.7 mat 2.8 mat glucose 16.7 m glucose
glucose 10 mM glyceraldehyde 10 M forskolin
Fig. 5. The effects of 16.7 mv D-glucose, 16.7 mw glucose and 10 ii
forskolin, and 10 m D-glyceraldehyde on cyclic AMP content of islets
from PW and PD rats. Each column represents mean value of 8 to 10
measurements and brackets denote 1 SE. Symbols are: (E) PW; (U) PD.
action of insulin. Our studies did not investigate the mecha-
nisms of such a resistance but rather addressed the issue of the
effect of PD on insulin secretion by the pancreatic islets.
Our results also showed that the plasma insulin levels during
the IVGTT in PD rats were significantly lower than in PW rats
and than those previously reported in normal rats [7]. These
data taken together with our finding that fasting plasma insulin
levels in PD rats were not higher than those in PW animals
despite the presence of fasting hyperglycemia in the former
group indicate that insulin secretion by the pancreatic islets of
PD rats is impaired. The results of our static and dynamic
studies demonstrating a significant reduction in both the initial
and total glucose-induced insulin release from pancreatic islets
of PD provide a direct evidence that PD impairs insulin secre-
tion.
The mechanisms involved in glucose-induced insulin release
are complex and not well understood. However, the available
data favors the substrate-site model [19] which encompasses
several steps. These include entry of glucose into the /3-cells by
a carrier-mediated process [20], metabolism of glucose by the
lonomycin (50 flM)
1
210
a I Normal
136
253 r-aC I
128 L_.
glycolytic pathway [21] to produce a compound(s) [22—24] that
would trigger other cellular events [19] leading to insulin
release. In addition, intact insulin secretion requires adequate
amount of insulin in the islets. Recent data assign an important
role for ATP in the process of insulin secretion [25, 26]. ATP
facilitates the closure of ATP-dependent potassium channels
[25—27] followed by cell depolarization [25,28] and activation of
voltage sensitive calcium channels [19, 25]. The latter event
permits calcium influx into islets, and the subsequent rise in
cytosolic calcium would contribute to insulin secretion [19, 25].
An abnormality in one or more of these processes may develop
during PD and hence impair insulin secretion.
I
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Fig. 6. A representative study of the intracellular calcium concentra-
tion measurements in dispersed islet cells form normal, PW and PD
rats. Fluorescence of Fura2 was monitored for a period 2 to 3 minutes.
The response to 50 n of ionomycin is also depicted.
126 Zhou et a!: Phosphate depletion and insulin secretion
The impaired insulin release from the islets in PD rats could
not be due to an abnormality in glucose entry into the p-cells
nor to a reduced insulin content of the islets, since the former
was not affected by PD and the latter was modestly higher in PD
than in PW rats. However, several observations in our study
indicate that abnormalities in glucose metabolism are present in
PD islets. These include the response to D-glyceraldehyde, the
reduced lactic acid output and the alterations in ATP content of
the islets isolated form PD rats.
Our data show that D-glyceraldehyde-induced insulin release
in PD rats is not impaired and is not different from that of PW
rats. Since glyceraldehyde enters the glycolytic pathway at the
triose phosphate isomerase level [211, it appears that the defect
in glucose-induced insulin release could be due to derangements
in steps of the glycolytic pathway prior to the production of
glyceraldehyde-3 phosphate. Our data provide support for such
a notion. After the entry of glucose into the islets, it is first
phosphorylated to glucose-6-phosphate, a process that requires
ATP. The glucose-6-phosphate is converted by an isomerase to
fructose-6-phosphate. The latter is further phosphorylated to
fructose 1,6 bisphosphate, which is then split into dihydroxy-
acetate and glyceraldehyde-3-phosphate. The decrease in ATP
content of the islets in PD rats could, therefore, impair the
phosphorylation of glucose and interfere with the conversion of
glucose to fructose 1,6 bisphosphate. Further support for an
impairment in glucose oxidation in islets from PD rats is found
by our observation that net lactic acid output by PD islets is
significantly (P < 0.01) lower than that in PW islets.
A demonstration of lower content of intermediate of glucose
metabolism such as glucose-6-phosphate, fructose 1,6 bisphos-
phate and glyceraldehyde-3-phosphate in islets from PD rats
would have provided a definite evidence for impaired glucose
oxidation. Unfortunately, we were unable to reliably measure
the pmole quantities of these compounds in the islets because of
the small amount of tissue available for the assay. However, we
have previously reported that PD is associated with significant
reduction in the content of these intermediates in the heart [29],
supporting the notion that PD could impair glucose metabolism
in cells.
Our studies demonstrate for the first time that phosphate
depletion affects resting cytosolic calcium. The levels of the
latter in the islets of PD rats were markedly elevated as
compared to the levels in islets of PW or normal rats. The
mechanisms responsible for this phenomenon are not delin-
eated by our studies. The resting levels of cytosolic calcium
represent the balance between the amount of calcium entering
the cell and those extruded out of the cell and those buffered by
intracellular structures. Thus, the rise in resting cytosolic
calcium of the islets in PD rats must reflect an imbalance
between these processes. Phosphate depletion may affect the
integrity of the cell membrane through an effect on its phospho-
lipids content and such a change may allow calcium to enter the
cell with greater ease and accumulate in it. Calcium-activated
ATPase [30—331 and Na/Ca2 exchanger [33—36] are the main
processes involved in the extrusion of calcium out of the cell.
Both pumps require ATP either directly or indirectly for their
functional integrity [32, 37, 381, and, therefore, a reduction in
ATP content of the islets of PD rats may adversely affect the
function of these pumps resulting in a rise in cytosolic calcium.
Our finding that ionomycin, which enhances calcium entry into
cells and mobilizes calcium from mitochondria and endoplasmic
reticulum [39], produced a sustained elevation in cytosolic
calcium of the islets of PD rats is consistent with impaired
extrusion of calcium out of the islets.
The effect of PD on resting cytosolic calcium of islets may
also play a pathogenetic role in the impaired insulin secretion in
PD. We have previously shown that an increase in total
pancreatic calcium in rats with chronic renal failure (CRF) or in
normal rats treated with parathyroid hormone [40] is associated
with impaired insulin release. Also parathyroidectomy of CRF
rats [40] or treatment of CRF rats with verapamil [71 prevented
calcium accumulation in pancreas and normalized insulin secre-
tion by the islets of these animals. Further, we found that the
islets of CRF rats [411 or of normal rats treated with PTH [42]
have significant elevation in resting levels of cytosolic calcium
and impaired insulin secretion. All these observations assign an
important role for a rise in resting cytosolic calcium of the islets
in the genesis of the impaired insulin secretion. it is, therefore,
plausible to suggest that the rise in resting cytosolic calcium in
the islets of PD rats plays an important role in the reduced
insulin secretion by these islets. It is worth emphasizing that
both the rise in resting cytosolic calcium and the impaired
insulin secretion by the islets of PD rats is not mediated by renal
insufficiency, since PD was not associated with a rise in serum
creatinine, and is not due to hyperparathyroidism, since PD rats
developed hypercalcemia and the latter suppresses the activity
of the parathyroid glands.
The reduced ATP content of islets from PD rats both in the
resting state and after exposure to 16.7 mvt D-glucose may
contribute to the impaired insulin secretion through the effect of
ATP on the ATP-dependent potassium channels [25—27]. Ade-
quate ATP is required for the closure of these channels with
subsequent cell depolarization and activation of voltage-depen-
dent calcium channels. The opening of the latter channels
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Fig. 7. Resting levels of cytosolic calcium of dispersed cells of islets
from normal, PW and PD rats. Each column represents the mean value
of 17 measurements obtained in 3 experiments and brackets denote 1
SE. Each experiment required 4 rats to provide 500 islets necessary for
the preparation of an adequate cell suspension. Symbols are: ()
normal; () PW; (U) PD.
Zhou et a!: Phosphate depletion and insulin secretion 127
permits calcium to enter the cell, an event that contributes to
the overall process of insulin secretion. Corkey et al [26]
postulated that a rise in ATP/ADP ratio may inhibit the ATP-
sensitive potassium channel with consequent depolarization of
the cell membrane, and opening of voltage-sensitive calcium
channel permitting calcium influx, which would stimulate insu-
lin secretion. Our finding of lower ATP/ADP ratio in, and
reduced glucose-induced insulin secretion by islets from PD
rats is consistent with the proposition of Corkey et al [261.
Several studies have reported that PD is associated with a fall
in ATP content in many organs. For example, ATP content of
red blood cells [431, white blood cells [44], platelets [451, kidney
[211 and heart [47] are reduced in PD. This has been attributed
to a fall in intracellular inorganic phosphorus and consequent
reduction in ATP production. A similar mechanism may explain
the fall in ATP content of the pancreatic islets of PD rats.
However, the rise in resting cytosolic calcium in the islets of PD
rats may also inhibit mitochondrial oxidation and ATP produc-
tion. Indeed, increased calcium accumulation inhibited mito-
chondrial oxidation in other organs such as heart [48] and
skeletal muscle [49], and was associated with lower ATP
content of these organs. We would like, therefore, to suggest
that two processes may be responsible for the reduced ATP
content in PD. The ATP content may initially fall as a conse-
quence of reduced content of inorganic phosphorus in cell. This
initial decrease in ATP content would impair calcium extrusion
by the cell resulting in a rise in resting cytosolic calcium, which
in turn would inhibit mitochondrial function and further reduce
ATP production and hence ATP content.
Finally, it is possible that the changes in serum calcium and
magnesium in PD rats played a part in the impaired insulin
secretion in these rats. However, the available data makes this
possibility unlikely. A rise in the concentration of plasma
calcium is associated with an increase in plasma levels of insulin
[50], and hypomagnesemia does not affect plasma insulin levels
[51].
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